Clinical Trial Update: mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing mFOLXOX6 to FOLFIRI for metastatic colorectal cancer after oxaliplatin-based adjuvant therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• mFOLXOX6

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN